Related Experiment Video
Updated: Jun 23, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Evaluation of the cases with acute disseminated encephalomyelitis
Ayse Tosun1, Gul Serdaroglu, Muzaffer Polat
1Department of Pediatrics, Division of Pediatric Neurology, Ege University Medical School Bornova, 35100, Izmir, Turkey.
Insights
Acute disseminated encephalomyelitis (ADEM) in children typically shows good recovery. Early steroid treatment is key for favorable outcomes, with rare neurological deficits or recurrence observed in this study.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Neuroimmunology
Background:
- Acute disseminated encephalomyelitis (ADEM) is an immune-mediated demyelinating disease affecting the central nervous system in children.
- Understanding ADEM's clinical spectrum, diagnostic features, and treatment outcomes is crucial for pediatric neurology.
Purpose of the Study:
- To comprehensively describe the epidemiologic, clinical, laboratory, neuroimaging, treatment, and outcome characteristics of pediatric ADEM.
- To identify factors influencing prognosis in children diagnosed with ADEM.
Main Methods:
- Retrospective review of twelve pediatric patients diagnosed with ADEM.
- Systemic and neurological examinations, serologic tests, cerebrospinal fluid analysis, and magnetic resonance imaging (MRI) were utilized for case reevaluation.
Main Results:
- The study cohort included children aged 2.5 to 16 years, with initial infections preceding ADEM in five cases.
- Common presentations included motor deficits (75%), altered consciousness (33%), and seizures (33%). MRI revealed hyperintense signals in basal ganglia, thalamus, and cortical/subcortical areas.
- Ten patients achieved complete recovery; one experienced relapse and two had recurrence, all responding well to prednisolone treatment.
Conclusions:
- Pediatric ADEM generally has a favorable prognosis with good recovery.
- Neurological deficits and recurrence are uncommon, underscoring the importance of early intervention.
- Prompt treatment with corticosteroids, such as prednisolone, significantly impacts the prognosis of ADEM in children.
Objective:
We aimed to describe the epidemiologic, clinical, laboratory features, neuroimaging, treatment, and outcome of children with acute disseminated encephalomyelitis in a cohort study.
Methods:
In this study, twelve children who were diagnosed as acute disseminated encephalomyelitis were reviewed retrospectively. All of the cases were reevaluated with systemic and neurological examinations, serologic tests, cerebrospinal fluid investigations, magnetic resonance imaging.
Result:
Their age ranged between 2.5 and 16 years. Five of the cases had initial infections. Patients presented most often with motor deficits (75%), secondly with loss of conscious (33%), and seizures (33%). Spinal fluid abnormalities occurred in 41.6%. Cranial, and spinal magnetic resonance imaging (MRI) revealed hyperintense signal changes mainly in basal ganglia and thalamus (58%), cortical and subcortical areas (33) in T2 weighted images. Myelitis was determined in two cases. Six patients were treated with steroid, and 3 were treated with intravenous immunoglobulin. Ten patients recovered completely. We observed relapse in one case and recurrence in two cases. These cases responded well to high dose intravenous prednisolone followed by oral prednisolone for 6 months.
Conclusion:
Outlook recovery is generally good in acute disseminated encephalomyelitis. Recurrence and neurological deficits are rarely seen. Early treatment of prednisolone is one of the most important factors to determine the prognosis in this disease.
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Viral Meningitis
Arboviral Encephalitis
Rocky Mountain Spotted Fever

